Observations & Predictions

Sales & Marketing

virtual electronic medical record interface

Sponsored

5 forces reshaping pharma commercialisation in 2026

As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment

Patients

Sponsored

From insight to impact: Why the patient voice will redefine ...

Is patient-centred trial design becoming a strategic advantage for mid-size pharma, helping cut risk, improve timelines, and engage patients?

Digital

Sponsored

The imperative for patient centricity in clinical research i...

Read uMotif's Observations & Predictions on the imperative for patient centricity and stronger patient-site relationships in clinical research.

R&D

Sponsored

Obesity, complexity, and the lab: What 2025 taught us, and w...

The complexity of working with the patient population in obesity continues to challenge traditional trial design. hVIVO looks to the year ahead.

Digital

Sponsored

Clinical trials at the core: Decentralised, AI targeted, ESG...

For Inventus' Steve Sanghera and Jim Michel 2025 was a year of progress in clinical trial enablement.

Sales & Marketing

Sponsored

The AI imperative: Establishing the standard for modern clin...

The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.

5 forces reshaping pharma commercialisation in 2026

From insight to impact: Why the patient voice will redefine ...

The imperative for patient centricity in clinical research i...

Obesity, complexity, and the lab: What 2025 taught us, and w...

Clinical trials at the core: Decentralised, AI targeted, ESG...

The AI imperative: Establishing the standard for modern clin...

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

Observations & Predictions

Editor's Picks